Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Tools
Free Benzinga Pro Trial
Calendars
Trade Ideas
Short Interest
Compare Best Stocks
Michael Okunewitch's Stock Ratings
Maxim Group Analyst
Michael Okunewitch is an analyst at Maxim Group. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 12/15/2025
Updated: Dec 15, 2025
Overall Average Return
-11.2%
Smart Score
Overall Average Return Percentile
16th
Number of Ratings
32
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 12/03/2025 | VNRX | Buy Now | VolitionRX | $0.23 | — | — | Downgrade | Buy → Hold | Get Alert | |
| 10/20/2025 | RANI | Buy Now | Rani Therapeutics Hldgs | $1.42 | 604.23% | $5 → $10 | Maintains | Buy | Get Alert | |
| 09/23/2025 | CTOR | Buy Now | Citius Oncology | $1.14 | 426.32% | → $6 | Upgrade | Hold → Buy | Get Alert | |
| 07/23/2025 | ANEB | Buy Now | Anebulo Pharmaceuticals | $2.33 | — | — | Downgrade | Buy → Hold | Get Alert | |
| 05/29/2025 | HCWB | Buy Now | HCW Biologics | $1.77 | 1877.4% | $120 → $35 | Maintains | Buy | Get Alert | |
| 05/23/2025 | CTOR | Buy Now | Citius Oncology | $1.14 | — | — | Downgrade | Buy → Hold | Get Alert | |
| 05/15/2025 | ANEB | Buy Now | Anebulo Pharmaceuticals | $2.33 | 28.76% | $6 → $3 | Maintains | Buy | Get Alert | |
| 05/01/2025 | RADX | Buy Now | Radiopharm Theranostics | $5.93 | 102.4% | → $12 | Initiates | → Buy | Get Alert | |
| 02/20/2025 | CMMB | Buy Now | Chemomab Therapeutics | $2.10 | 233.33% | $4 → $7 | Maintains | Buy | Get Alert | |
| 02/14/2025 | MYNZ | Buy Now | Mainz Biomed | $1.01 | 1286.14% | → $14 | Initiates | → Buy | Get Alert | |
| 01/10/2025 | LCTX | Buy Now | Lineage Cell Therapeutics | $1.72 | 74.42% | $5 → $3 | Maintains | Buy | Get Alert | |
| 11/27/2024 | CTOR | Buy Now | Citius Oncology | $1.14 | 163.16% | → $3 | Initiates | → Buy | Get Alert | |
| 10/15/2024 | OCGN | Buy Now | Ocugen | $1.37 | 191.97% | → $4 | Initiates | → Buy | Get Alert | |
| 09/24/2024 | FBLG | Buy Now | FibroBiologics | $0.25 | 4727.03% | → $12 | Initiates | → Buy | Get Alert | |
| 08/27/2024 | LGVN | Buy Now | Longeveron | $0.56 | 979.14% | $15 → $6 | Maintains | Buy | Get Alert | |
| 05/13/2024 | CMMB | Buy Now | Chemomab Therapeutics | $2.10 | 90.48% | → $4 | Initiates | → Buy | Get Alert | |
| 03/05/2024 | LEXX | Buy Now | Lexaria Bioscience | $0.86 | 1293.73% | $3 → $12 | Maintains | Buy | Get Alert | |
| 12/07/2023 | DMK | Buy Now | DMK Pharmaceuticals | — | — | → $1.5 | Initiates | → Buy | Get Alert | |
| 10/05/2023 | ACRV | Buy Now | Acrivon Therapeutics | $2.49 | 863.86% | → $24 | Initiates | → Buy | Get Alert | |
| 09/21/2023 | ANEB | Buy Now | Anebulo Pharmaceuticals | $2.33 | 157.51% | → $6 | Initiates | → Buy | Get Alert | |
| 08/09/2023 | KPRX | Buy Now | Kiora Pharmaceuticals | $2.12 | -5.75% | $12 → $2 | Maintains | Buy | Get Alert | |
| 07/21/2023 | LEXX | Buy Now | Lexaria Bioscience | $0.86 | 132.29% | → $2 | Initiates | → Buy | Get Alert | |
| 04/12/2023 | ALZN | Buy Now | Alzamend Neuro | $2.13 | -29.58% | → $1.5 | Initiates | → Buy | Get Alert | |
| 02/09/2023 | KPRX | Buy Now | Kiora Pharmaceuticals | $2.12 | 465.5% | → $12 | Upgrade | Hold → Buy | Get Alert | |
| 12/22/2022 | MDWD | Buy Now | MediWound | $18.99 | 31.65% | → $25 | Initiates | → Buy | Get Alert | |
| 09/28/2022 | BRTX | Buy Now | BioRestorative Therapies | $1.15 | 421.74% | → $6 | Initiates | → Buy | Get Alert | |
| 08/15/2022 | KPRX | Buy Now | Kiora Pharmaceuticals | $2.12 | — | — | Downgrade | Buy → Hold | Get Alert | |
| 03/24/2022 | HCWB | Buy Now | HCW Biologics | $1.77 | 125.99% | → $4 | Initiates | → Buy | Get Alert | |
| 03/24/2022 | LGVN | Buy Now | Longeveron | $0.56 | 2417.99% | → $14 | Initiates | → Buy | Get Alert | |
| 02/09/2022 | SQL | Buy Now | SeqLL | — | — | → $3 | Initiates | → Buy | Get Alert | |
| 11/30/2021 | ATAI | Buy Now | ATAI Life Sciences | $4.10 | 509.76% | → $25 | Initiates | → Buy | Get Alert | |
| 11/30/2021 | CTXR | Buy Now | Citius Pharma | $1.07 | 272.09% | → $4 | Initiates | → Buy | Get Alert |
Market Resources
Trading Tools & Education
- Benzinga Pro Trading Platform
- Options Trading Strategies and News
- Stock Market Trading Ideas and Analysis
- Technical Analysis Charts and Indicators
- Fundamental Analysis and Valuation
- Day Trading Guides and Strategies
- Live Investors Events
- Pre market Stock Analysis and News
- Cryptocurrency Market Analysis and News
Ring the Bell
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.
© 2025 Benzinga | All Rights Reserved